Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2025 > Vol 6, №7 (2025) > Neuroendocrine tumors of the stomach and H. pylori infection: features of patient monitoring on the example of a clinical case

Neuroendocrine tumors of the stomach and H. pylori infection: features of patient monitoring on the example of a clinical case

Margarita D. Kozlova , Ilya I. Kovrigin , Natalya N. Dekhnich

For citation:


  • Abstract
  • About the Author
  • References

Abstract

In this clinical case, we present an observation of a 36-year-old patient with a highly differentiated neuroendocrine tumor (NEO) of the stomach (NET G2, Ki-67.7%), which developed against the background of autoimmune gastritis and persistent infection with Helicobacter pylori (H. pylori). Despite the absence of detection of H. pylori during histological examination, the infection was confirmed by the determination of the H. pylori antigen in feces by enzyme immunoassay (ELISA), which confirms the need for a comprehensive diagnosis of the pathogen in this category of patients. The clinical case demonstrates the relationship between autoimmune gastritis, H. pylori infection and the development of NEO, and also confirms the effectiveness of a multidisciplinary approach in the treatment of such clinical situations. 
Keywords: neuroendocrine tumor of the stomach, autoimmune gastritis, Helicobacter pylori, hypergastrinemia, octreotide, eradication therapy.

About the Author

Margarita D. Kozlova 1 2 , Ilya I. Kovrigin 1 , Natalya N. Dekhnich 1 2

1 Smolensk State Medical University, Smolensk, Russia

2 Clinical Hospital №1, Smolensk, Russia

References

1. Modlin IM, Lye KD, Kidd MA. 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934-59. 
2. Burkitt MD, Pritchard DM. Review article: Pathogenesis and management of gastric carcinoid tumours. Aliment Pharmacol Ther. 2006 Nov 1;24(9):1305-20. DOI: 10.1111/j.1365-2036.2006.03130.x 
3. Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35825 cases in the United States. J Clin Oncol. 2008;26:3063-72. 
4. Артамонова ЕВ, Бельцевич ДГ, Гелиашвили ТМ и др. Нейроэндокринные опухоли. Клинические рекомендации. М., 2020. Artamonova EV, Beltsevich DG, Geliashvili TM, et al. Neuroendocrine tumors. Clinical guidelines. Moscow, 2020 (in Russian). 
5. Hooi JKY, Lai WY, Ng WK, et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017;153(2):420-9. 
6. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res. 1992;52(24):6735-40. 
7. Delle Fave G, O’Toole D, Sundin A, et al. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms. Neuroendocrinology. 2016;103:119-24. 
8. Jianu CS, Fossmark R, Viset T, et al. Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment Pharmacol Ther. 2012;36(7):644-9. 9. Scherübl H, Cadiot G, Jensen RT, et al. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy. 2010;42(08):664-71. 
10. Rindi G, Klöppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Archiv. 2007;451(4):757-62. 
11. Borch K, Ahrén B, Ahlman H, et al. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg. 2005;242(1):64-73. 
12. Massironi S, Sciola V, Spampatti MP, et al. Gastric carcinoids: between underestimation and overtreatment. World J Gastroenterol. 2009;15(18):2177-83.

For citation: Kozlova M.D., Kovrigin I.I., Dekhnich N.N. Neuroendocrine tumors of the stomach and H. pylori infection: features of patient monitoring on the example of a clinical case. Clinical review for general practice. 2025; 6 (7): 76–80 (In Russ.). DOI: 10.47407/kr2025.6.7.00647


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

Scopus
doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru